Figure 3.

The level of miR-152 was elevated with advanced cervical cancer stage. (A) The median level of SCC-Ag prior to treatment in the early stages of patients with CIN and cervical cancer was lower compared with that of advanced stages. (B) Reverse transcription-quantitative polymerase chain reaction analysis of the miR-152 expression level at different stages of CIN and cervical cancer. *P<0.05, **P<0.01, ***P<0.001 vs. healthy controls (one-way analysis of variance followed by Turkey post hoc test). miR-152, microRNA-152; SCC-Ag, squamous cell carcinoma antigen; CIN, cervical intraepithelial neoplasia.